Michael Borger of the Leipzig Heart Center in Germany presents an overview of surgical repair for ischemic mitral regurgitation.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Heart failure
November 16, 2017
Joseph Lamelas of the Texas Heart Institute in Houston discusses different surgical techniques to address ventricular dysfunction in functional mitral regurgitation.
November 16, 2017
The incoming issue of the Journal comes with an interesting group of papers revolving around a provocative topic: work from Seattle on the absence of predictive value of standard pulmonary function tests in LVAD surgery. Vivek Rao takes the opportunity to present his thoughts in this brief editorial, the important central message of which cannot be
November 15, 2017
With the impressive average of 150 mitral repairs annually for the last 16 years (possibly a world record, even more impressive given the population of Portugal), the Coimbra team led by Antunes reflects on six cases of circumflex artery injury, mostly in non-right dominant anatomy as expected.
November 13, 2017
The Hospital Readmissions Reduction Program (HRRP) was established as part of the Affordable Care Act in the US with the goal of adding an incentive for quality care that reduced hospital readmission rates. HRRP reduces Medicare reimbursement for hospitals with excess readmissions.
November 3, 2017
Patient Care
Ambulances specially tailored to respond to cardiac emergencies will go into service in Goa, India, at the beginning of 2018.
November 3, 2017
Kamperidis and colleagues report that left ventricular (LV) functional recovery after mitral valve (MV) repair for severe secondary mitral regurgitation is associated with improved patient outcomes.
October 27, 2017
A measured succinct reflection on MagLev and older ventricular assist devices, on the occasion of a relevant 'expert opinion' paper on the topic.
October 20, 2017
Patient Care
The “I Love Life” campaign to raise awareness of heart failure in Egypt launched this week.
October 12, 2017
The Impella RP device was approved by the FDA for use as a temporary percutaneous assist for the right ventricle, as announced by Abiomed. Use is approved for up to 14 days for a variety of indications including post MI, heart transplant, open heart surgery, or right heart failure after LVAD implant.